These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8649940)

  • 41. Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD).
    Tripepi G; Mattace-Raso F; Pizzini P; Cutrupi S; Witteman J; Zoccali C; Mallamaci F
    J Nephrol; 2012; 25(1):75-83. PubMed ID: 21534240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
    Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W
    Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The measurement of calcium-regulating hormones in clinical medicine.
    Posen S; Clifton-Bligh P; Mason RS
    Prog Biochem Pharmacol; 1980; 17():220-7. PubMed ID: 7208501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CKD patients: the dilemma of serum PTH levels.
    Pontoriero G; Cozzolino M; Locatelli F; Brancaccio D
    Nephron Clin Pract; 2010; 116(4):c263-8. PubMed ID: 20639672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum bioactive parathyroid hormone in hemodialysis patients.
    McCarthy JT; Klee GG; Kao PC; Hodgson SF
    J Clin Endocrinol Metab; 1989 Feb; 68(2):340-5. PubMed ID: 2918050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intact parathyroid hormone, ionized calcium and calcium infusion test in the evaluation of hyperparathyroidism in chronic renal failure.
    Pietilä K; Mörsky P; Pasternack A; Mustonen J; Koivula T
    Nephron; 1987; 47(4):284-9. PubMed ID: 3696331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pruritus and mast cell proliferation of the skin in end stage renal failure.
    Matsumoto M; Ichimaru K; Horie A
    Clin Nephrol; 1985 Jun; 23(6):285-8. PubMed ID: 4028525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variability in measures of mineral metabolism in children on hemodialysis: impact on clinical decision-making.
    Kakajiwala A; Jemielita TO; Copelovitch L; Leonard MB; Furth SL; York A; Benton M; Hoofnagle AN; Windt K; Merrigan K; Lederman A; Denburg MR
    Pediatr Nephrol; 2017 Dec; 32(12):2311-2318. PubMed ID: 28667458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of growth hormone treatment on bone metabolism in dialysis patients.
    Sieniawska M; Pañczyk-Tomaszewska M; Ziólkowska H
    Br J Clin Pract Suppl; 1996 Aug; 85():61-3. PubMed ID: 8995036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Calcium-phosphate disturbances in dialysed children and adolescents--one centre analysis between 1991-2008].
    Jander A; Kałuzyńska A; Tkaczyk M
    Pol Merkur Lekarski; 2010 Jan; 28(163):18-21. PubMed ID: 20369717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
    Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
    Perit Dial Int; 1996; 16 Suppl 1():S567-9. PubMed ID: 8728272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Proceedings: Anomaly of calcium metabolism in the bone in hemodialysis patients. 3. Fluctuation of serum PTH levels].
    Imai T; Takatsuki K; Fujita T; Mitauma T; Nihei R
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):596. PubMed ID: 4476598
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hyperparathyroidism in hemodialysis patients: studies on parathyroid regulation and classification problems (author's transl)].
    Augustin R; Hackeng WH
    Klin Wochenschr; 1981 Nov; 59(22):1251-9. PubMed ID: 7311395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parathyroid gland function in chronic renal failure.
    Felsenfeld AJ; Llach F
    Kidney Int; 1993 Apr; 43(4):771-89. PubMed ID: 8479113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Test with calcitonin as an index of parathyroid function in chronic renal failure].
    Matuszkiewicz-Rowińska J; Niemczyk S; Bogdańska-Straszyńska B; Ostrowski K
    Pol Arch Med Wewn; 1993 Feb; 89(2):102-6. PubMed ID: 8502592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of hemodialysis on serum N-PTH 1-34 and C-PTH 1-84 in renal failure (author's transl)].
    Uezu A; Ota K; Fujita T
    Nihon Jinzo Gakkai Shi; 1979 Jan; 21(1):23-32. PubMed ID: 571930
    [No Abstract]   [Full Text] [Related]  

  • 57. Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.
    Frazao J; Coburn JW
    Am J Kidney Dis; 1995 Nov; 26(5):831-5. PubMed ID: 7485141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation.
    Avram MM; Mittman N; Myint MM; Fein P
    Am J Kidney Dis; 2001 Dec; 38(6):1351-7. PubMed ID: 11728974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiency.
    Ledermann SE; Johnson A; Dillon MJ; Trompeter RS; Barratt TM
    Pediatr Nephrol; 1994 Oct; 8(5):561-5. PubMed ID: 7819001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients.
    Ghosh-Narang J; Jones TM; Menke A; Todd AC; Muntner P; Batuman V
    Am J Med Sci; 2007 Dec; 334(6):415-20. PubMed ID: 18091361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.